title: How long to treat acute venous thrombosis in cancer: can treatment be personalized?
authors.affiliation: McMaster University; Juravinski Cancer Centre; and Escarpment Cancer Research Institute; Hamilton, Ontario, Canada.
authors.forename: Punam
authors.initials: P
authors.lastname: Rana
authors.affiliation: McMaster University; Juravinski Cancer Centre; and Escarpment Cancer Research Institute; Hamilton, Ontario, Canada mlevine@mcmaster.ca.
authors.forename: Mark N
authors.initials: MN
authors.lastname: Levine
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D009369:Neoplasms / Q000150:complications*; D054556:Venous Thromboembolism / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy*
chemical_list: D006495:Heparin, Low-Molecular-Weight